Both in Pharmaceuticals
Cartesian Therapeutics vs Evommune
Over the past year RNAC returned −15.1% and EVMN returned −70.6%; their daily moves had a correlation of 0.07.
RNAC −15.1% EVMN −70.6%Growth of $1, one year, split-adjusted
| Metric | RNAC | EVMN |
|---|---|---|
| Price | $6.41 | $5.94 |
| Market cap | $193.9M | $215.6M |
| Today | +1.10% | −1.16% |
| 1 month | −10.2% | −10.7% |
| 6 months | −13.3% | −75.4% |
| Year to date | −11.1% | −65.3% |
| 1 year | −21.5% | — |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 131.3× | — |
| Net cash | $94.8M | $200.4M |
| Dividend yield | — | — |
| Volatility (60d) | 49.0% | 87.1% |
| Short % of float | 15.6% | 15.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).